BE550159A - - Google Patents

Info

Publication number
BE550159A
BE550159A BE550159DA BE550159A BE 550159 A BE550159 A BE 550159A BE 550159D A BE550159D A BE 550159DA BE 550159 A BE550159 A BE 550159A
Authority
BE
Belgium
Prior art keywords
sep
ferrous
iron
complex
compounds
Prior art date
Application number
Other languages
English (en)
French (fr)
Publication of BE550159A publication Critical patent/BE550159A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/295Iron group metal compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE550159D BE550159A (ca)

Publications (1)

Publication Number Publication Date
BE550159A true BE550159A (ca)

Family

ID=176147

Family Applications (1)

Application Number Title Priority Date Filing Date
BE550159D BE550159A (ca)

Country Status (1)

Country Link
BE (1) BE550159A (ca)

Similar Documents

Publication Publication Date Title
Li Iodination of Tyrosine Groups in Serum Albumin and Pepsin1
CN104673865B (zh) 具有降尿酸作用的秋刀鱼美拉德肽及其制备方法和用途
Xu et al. A biomimetic nanodrug self-assembled from small molecules for enhanced ferroptosis therapy
Zingales et al. Role of quercetin on sterigmatocystin-induced oxidative stress-mediated toxicity
BE550159A (ca)
Tesei et al. NCX 4040, an NO-donating acetylsalicylic acid derivative: efficacy and mechanisms of action in cancer cells
CN117466286A (zh) 一种基于大黄酸的红色荧光碳量子点及其制备方法
PT2323625T (pt) Nova composição para o tratamento de pigmentações equimóticas
CN106214632A (zh) 一种对乙酰氨基酚、双氯芬酸钠注射液及其制备方法
CN117384374A (zh) FTEP-TBFc化合物的制备方法和在抗肿瘤中的应用
CN106999455A (zh) 改性牛磺酸以及含有改性牛磺酸的用于预防或治疗代谢疾病的药物组合物
DuBourdieu et al. Curcuminoid–metal complexes for oxidative stress
JPS6355489B2 (ca)
CN106478946A (zh) 一种可降解的聚苯胺/多孔硅纳米复合材料及其制备方法和应用
CN101400262A (zh) 新植酸柠檬酸化合物及其制备方法
BE897980A (fr) Procede pour la preparation d'une solution a usage pharmaceutique contenant un nouveau complexe mixte polynuclaire de fer (iii) comme ingredient actif
US736529A (en) Formaldehyde compound.
CN107638567A (zh) 一种金属罗森黑盐及其制备方法和用途
CN101309976B (zh) 高纯度德克萨卟啉金属配合物
US10413570B2 (en) Method of manufacturing a zinc compound lozenge
JP4678661B2 (ja) 新規なテトラキスアミノフェニル(ジ)フェニレンジアミン骨格を有する化合物
JP2024025110A (ja) 光線力学的療法のための光感受性物質
AT77319B (de) Verfahren zur Darstellung von wasserlöslichen Verbindungen des Cystins und dessen Derivaten mit Desinfizientien zur Bekämpfung von Typhus und anderen Infektionskrankheiten, die in der Leber ihrer Ursprung haben.
JPS58148850A (ja) プロピオニルグリシン誘導体、その製造方法及びそれを活性成分として含む治療用組成物
BE440267A (ca)